Pain in Women pp 155-172 | Cite as


  • Jennifer Gunter


Chronic vulvar pain affects 3–10 % of women with a similar prevalence among white and African-American women [1–4]. Previously termed vulvodynia and vestibulitis, chronic vulvar pain syndromes have been reclassified by the International Society for the Study of Vulvovaginal Disease (ISSVD) as spontaneous or provoked pain with further subtyping based on location, i.e., generalized versus localized (Table 6.1) [5, 6]. Dyspareunia, which affects up to 22 % of women, is an almost universal finding among women with vulvodynia and is classified as primary (present from first attempt at coitus or tampons) to secondary (developing sometime after pain-free intercourse has been established) [7].


Neuropathic Pain Irritable Bowel Syndrome Pelvic Floor Pelvic Floor Muscle Bacterial Vaginosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Danielsson I, Sjöhom I, Stenlund H, Wikman M. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health. 2003;31:113–18.PubMedCrossRefGoogle Scholar
  2. 2.
    Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58: 82–8.PubMedGoogle Scholar
  3. 3.
    Reed BD, Crawford S, Couper M, Cave C, Haefner H. Pain at the vulvar vestibule: a web-based survey. J Low Genit Tract Dis. 2004;8:48–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Arnold LD, Bachmann GA, Rosen R, Rhoads GG. Assessment of vulvodynia symptoms in a sample of U.S. women: a prevalence survey with a nested case control. Am J Obstet Gynecol. 2007;196:128.e1–6.CrossRefGoogle Scholar
  5. 5.
    Haefner HK, Collins ME, Davis GD, et al. The vulvodynia guideline. J Low Genit Tract Dis. 2005;9:40–51.PubMedCrossRefGoogle Scholar
  6. 6.
    Gunter J. Vulvodynia: new thoughts on a devastating condition. Obstet Gynecol Surv. 2007;62:812–19.PubMedCrossRefGoogle Scholar
  7. 7.
    Steege JF, Zolnoun DA. Evaluation and treatment of dyspareunia. Obstet Gynecol. 2009;113: 1124–36.PubMedGoogle Scholar
  8. 8.
    Reed BD, Haefner HK, Harlow SD, Gorenflo DW, Sen A. Reliability and validity of self-reported symptoms for predicting vulvodynia. Obstet Gynecol. 2006;108:906–13.PubMedCrossRefGoogle Scholar
  9. 9.
    Bergeron S, Binik YM, Khalifé S, Pagidas K, Glazer HI. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol. 2001;98:45–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Siddall PJ, Cousins MJ. Neurobiology of pain. Int Anesthesiol Clin. 1997;35:1–26.PubMedCrossRefGoogle Scholar
  11. 11.
    Omoigui S. The biochemical origin of pain: the origin of all pain is inflammation and the inflammation response. Part 2 of 3—inflammatory profile of pain syndromes. Med Hypotheses. 2007;69:1169–78.PubMedCrossRefGoogle Scholar
  12. 12.
    Gunter J. Neurobiology of chronic pelvic pain. In: Potts J, editor. Genitourinary pain and inflammation. Totowa: Humana Press; 2008. p. 3–17.CrossRefGoogle Scholar
  13. 13.
    Kolesnikov Y, El-Maarouf A, Rutishauser U, Pasternak G. Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia. Eur J Pharmacol. 2007;568(1–3):124–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Salter MW. Cellular neuroplasticity mechanisms mediating pain persistence. J Orofac Pain. 2004;18:318–24.PubMedGoogle Scholar
  15. 15.
    Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjörk E. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain. 2001;94:177–83.PubMedCrossRefGoogle Scholar
  16. 16.
    Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulvar vestibule in patients with vulvodynia. Br J Dermatol. 2003;148:1021–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest. 2004;58:171–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Halperin R, Zehavi S, Vaknin Z, Ben-Ami I, Pansky M, Schneider D. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest. 2005;59:75–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Tympanidis P, Casula MA, Yiangou Y, et al. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain. 2004;8:129–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Bornstein J, Cohen Y, Zarfati D, Sela S, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol. 2008;27:136–41.PubMedCrossRefGoogle Scholar
  21. 21.
    Zolnoun D, Hartmann K, Lamvu G, et al. A conceptual model for the pathophysiology of vulvar vestibulitis syndrome. Obstet Gynecol Surv. 2006;61:395–401.PubMedCrossRefGoogle Scholar
  22. 22.
    Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med. 2004;49:503–9.PubMedGoogle Scholar
  23. 23.
    Gerber S, Bongiovanni AM, Ledger WJ, et al. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2002;186:696–700.PubMedCrossRefGoogle Scholar
  24. 24.
    Gerber S, Bongiovanni AM, Ledger WJ, et al. Interleukin-1β gene polymorphisms in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol. 2003;107:74–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Meyer RA, Ringkamp M, Campbell JN, Raja SN. Peripheral mechanisms of cutaneous nociception, chapter 1. In: McMahon SB, Koltzenburg M, editors. Wall and Melzack’s textbook of pain. 5th ed. Amsterdam: Elsevier; 2006. p. 1.Google Scholar
  26. 26.
    Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain. 2006;7(1S):S3–12.PubMedGoogle Scholar
  27. 27.
    Heavner JE, Willis DJ. Pain pathways: anatomy and physiology, chapter 10. In: Raj PP, editor. Pain medicine. St. Louis: Mosby; 2003. p. 10–5.Google Scholar
  28. 28.
    Chen H, Lamer TJ, Rho R, Marshall KA, Sitzman BT, Ghazi SM, Brewer RP. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc. 2004;79:1533–45.PubMedCrossRefGoogle Scholar
  29. 29.
    Nyirjesy P, Peyton C, Weitz MV, Mathew L, Culhane JF. Causes of chronic vaginitis: analysis of a prospective database of affected women. Obstet Gynecol. 2006;108:1185–91.PubMedCrossRefGoogle Scholar
  30. 30.
    Harlow BL, He W, Nguyen RH. Allergic reactions and the risk of vulvodynia. Ann Epidemiol. 2009;19:771–7.PubMedCrossRefGoogle Scholar
  31. 31.
    De Knott R, McCormick HM, Do TS, et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis. 2005;53:214–18.CrossRefGoogle Scholar
  32. 32.
    Granot M, Friedman M, Yarnitsky D, et al. Enhancement of the perception of systemic pain in women with vulvar vestibulitis. Br J Obstet Gynecol. 2002;109:863–6.CrossRefGoogle Scholar
  33. 33.
    Granot M, Friedman M. Primary and secondary vulvar vestibulitis syndrome: systemic pain perception and psychophysical characteristics. Am J Obstet Gynecol. 2004;191:138–42.PubMedCrossRefGoogle Scholar
  34. 34.
    Foster DC, Dworkin RH, Wood RW. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-affected women. Pain. 2005;117:128–36.PubMedCrossRefGoogle Scholar
  35. 35.
    Kahn BS, Tatro C, Parsons CL, Willems JJ. Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity. J Sex Med. 2010;7(2 Pt 2):996–1002.PubMedCrossRefGoogle Scholar
  36. 36.
    Arnold JD, Bachman GS, Rosen R, et al. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006;107:617–24.PubMedCrossRefGoogle Scholar
  37. 37.
    Parsons CL, Dell J, Stanford EJ, et al. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol. 2002;187:1395–400.PubMedCrossRefGoogle Scholar
  38. 38.
    Clemens JQ, Meenan RT, O’Keefe Rosetti MC, et al. Prevalence of interstitial cystitis symptoms in a managed care population. J Urol. 2005;174:576–80.PubMedCrossRefGoogle Scholar
  39. 39.
    Mertz HR. Irritable bowel syndrome. N Eng J Med. 2003;349:2136–46.CrossRefGoogle Scholar
  40. 40.
    Engman M, Lindehammar H, Wijma B. Surface electromyography diagnostics in women with or without vulvar vestibulitis and in asymptomatic women. J Psychosom Obstet Gynecol. 2004;25:281–94.CrossRefGoogle Scholar
  41. 41.
    Vodusek DB. Anatomy and neurocontrol of the pelvic floor. Digestion. 2004;69:87–92.PubMedCrossRefGoogle Scholar
  42. 42.
    Rogers RM. Basic pelvic neuroanatomy. In: Steege JF, Metzger DA, Levy BS, editors. Chronic pelvic pain: an integrated approach. Philadelphia: WB Saunders; 1998. p. 31–58.Google Scholar
  43. 43.
    Barber MD, Bremer RE, Thor KB, Dolber PC, Kuehl TJ, Coates KW. Innervation of the female levator ani muscles. Am J Obstet Gynecol. 2002;187:64.PubMedCrossRefGoogle Scholar
  44. 44.
    Robinson DR, Gebhart GF. Inside information—the unique features of visceral sensation. Mol Interv. 2008;8:242–53.PubMedCrossRefGoogle Scholar
  45. 45.
    Jänig W, Haput-Schade P, Kohler W. Afferent innervation of the colon: the neurophysiologic basis for visceral sensitization and pain. In: Mayer EA, Raybould HE, editors. Basic and clinical aspects of chronic abdominal pain: pain research and clinical management. Amsterdam: Elsevier Sciences; 1993. p. 71–86.Google Scholar
  46. 46.
    Doggweiler R, Jasmin L, Schmidt RA. Neurogenically mediated cystitis in rats: an animal model. J Urol. 1998;160:1551–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Jasmin L, Janni G, Ohara PT, Rabkin SD. CNS induced neurogenic cystitis is associated with mast cell degranulation in the rat. J Urol. 2000;164(3 Pt 1):852–5.PubMedGoogle Scholar
  48. 48.
    Wesselman U. Neurogenic inflammation and chronic pelvic pain. World J Urol. 2001;19:180–5.CrossRefGoogle Scholar
  49. 49.
    Berkley KJ, Hubscher CH, Wall PD. Neuronal responses to stimulation of the cervix, uterus, colon, and skin in the rat spinal cord. J Neurophysiol. 1993;69:545–56.PubMedGoogle Scholar
  50. 50.
    Winnard KP, Bmitrieva N, Berkley KJ. Cross-organ interactions between reproductive, gastrointestinal, and urinary tracts: modulation by estrous stage and involvement of the hypogastric nerve. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1592–601.PubMedCrossRefGoogle Scholar
  51. 51.
    Wesselman U, Lai J. Mechanisms of referred visceral pain: uterine inflammation in the adult virgin rat results in neurogenic plasma extravasation in the skin. Pain. 1997;73:309–17.CrossRefGoogle Scholar
  52. 52.
    Reissing ED, Brown C, Lord MJ, Binik YM, Khalifé S. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynecol. 2005;26:107–13.CrossRefGoogle Scholar
  53. 53.
    Pukall CF, Strigo IA, Binik YM, et al. Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome. Pain. 2005;115:118–22.PubMedCrossRefGoogle Scholar
  54. .
  55. 54.
    Gordon AS, Panahlan-Jand M, McComb F, et al. characteristics of women with vulvar pain disorders: a web-based survey. J Sex Martial Ther. 2003;29 Suppl 1:45–58.Google Scholar
  56. 55.
    Whitten C, Cristobal K. Chronic pain is a chronic condition not just a symptom. Permanente J. 2005;9:43–51.Google Scholar
  57. 56.
    Manchikanti L, Fellows B, Pampati V, Beyer C, Damron K, Barnhill RC. Comparison of the psychological status of chronic pain patients and the general population. Pain Physician. 2002;5:40–8.PubMedGoogle Scholar
  58. 57.
    Banks SM, Kerns RD. Explaining the high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull. 1996;119:95–110.CrossRefGoogle Scholar
  59. 58.
    Sadownik LA. Clinical correlates of vulvodynia patients. A prospective study of 300 patients. J Reprod Med. 2000;45:679–84.PubMedGoogle Scholar
  60. 59.
    Reed BD, Haefner HK, Punch MR, Roth RS, Gorenflo DW, Gillespie BW. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation. J Reprod Med. 2000;45:624–32.PubMedGoogle Scholar
  61. 60.
    Landry T, Bergeron S. Biopsychosocial factors associated with dyspareunia in a community sample of adolescent girls. Arch Sex Behav. 2011;40(5):877–89.PubMedCrossRefGoogle Scholar
  62. 61.
    Delgado PL. Common pathways of pain and depression. J Clin Psychiatry. 2004;65 Suppl 12:16–9.PubMedGoogle Scholar
  63. 62.
    Obata K, Noguchi K. BDNF in sensory neurons and chronic pain. Neurosci Res. 2006;55:1–10.PubMedCrossRefGoogle Scholar
  64. 63.
    McEwan BS. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci. 2001;933:265–77.CrossRefGoogle Scholar
  65. 64.
    Arnow B, Hunker EM, Blasey CM, et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom Med. 2006;68:262–8.PubMedCrossRefGoogle Scholar
  66. 65.
    Harlow BL, Gunther Stewart E. Adult-onset vulvodynia in relation to childhood violence victimization. Am J Epidemiol. 2005;161:871–80.PubMedCrossRefGoogle Scholar
  67. 66.
    Dalton VK, Haefner HK, Reed BD, Senapati S, Cook A. Victimization in patients with vulvar dysesthesia/vestibulodynia. Is there an increased prevalence? J Reprod Med. 2002;47:829–34.PubMedGoogle Scholar
  68. 67.
    Kawamura N, Kim Y, Asukai N. Suppression of cellular immunity in men with past history of posttraumatic stress disorder. Am J Psychiatry. 2001;158:484–6.PubMedCrossRefGoogle Scholar
  69. 68.
    Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci. 2001;24:1161–92.PubMedCrossRefGoogle Scholar
  70. 69.
    Bjorling DE, Wang ZY. Estrogen and neuroinflammation. Urology. 2001;6 Suppl 1:40–6.CrossRefGoogle Scholar
  71. 70.
    Ting AY, Blacklock AD, Smith PG. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod. 2004;71:1397–404.PubMedCrossRefGoogle Scholar
  72. 71.
    Unruh AM. Gender variations in the clinical pain experience. Pain. 1996;65:123–76.PubMedCrossRefGoogle Scholar
  73. 72.
    Kushner L, Moldwin RM. Efficiency of questionnaires used to screen for interstitial cystitis. J Urol. 2006;176:587–92.PubMedCrossRefGoogle Scholar
  74. 73.
    Drossman DA, Dumitrascu DL. Rome III: new standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):237–41.PubMedGoogle Scholar
  75. 74.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.PubMedCrossRefGoogle Scholar
  76. 75.
    Davidson JR, Feltner DE, Dugar A. Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs. Prim Care Companion J Clin Psychiatry. 2010;12(2): e1–e13.Google Scholar
  77. 76.
    Gunter J. Chronic pelvic pain: an integrated approach to diagnosis and treatment. Obstet Gynecol Surv. 2003;58:615–23.PubMedCrossRefGoogle Scholar
  78. 77.
    Ferage MA, Miller KW, Ledger WJ. Determining the cause of vulvovaginal symptoms. Obstet Gynecol Surv. 2008;63:445–64.CrossRefGoogle Scholar
  79. 78.
    Gunter J. Chronic pelvic pain: the myofascial component. Female Patient. 2004;29:9–16.Google Scholar
  80. 79.
    Butrick CW. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am. 2009;36:707–22.PubMedCrossRefGoogle Scholar
  81. 80.
    Labat JJ, Riant T, Robert R, Amarenco G, Lefaucheur JP, Rigaud J. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn. 2008;27(4):306–10.PubMedCrossRefGoogle Scholar
  82. 81.
    Metts JF. Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management. Am Fam Physician. 1999;59(6):1547–60.PubMedCrossRefGoogle Scholar
  83. .
  84. 82.
    Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med. 1991;36:879–82.PubMedGoogle Scholar
  85. 83.
    Harlow BL, Abenhaim HA, Vitonis AF, Harnack L. Influence of dietary oxalates on the risk of adult-onset vulvodynia. J Reprod Med. 2008;53:171–8.PubMedGoogle Scholar
  86. 84.
    Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol. 1997;177:507–11.PubMedCrossRefGoogle Scholar
  87. 85.
    Foster DC, Kotok MB, Huang L, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116:583–93.PubMedCrossRefGoogle Scholar
  88. 86.
    Nickel JC. Interstitial cystitis: characterization and management of an enigmatic urologic syndrome. Rev Urol. 2002;4(3):112–21.PubMedGoogle Scholar
  89. 87.
    Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr. 2006;25(6): 514–22.PubMedGoogle Scholar
  90. 88.
    Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled trial. Sex Transm Infect. 2001;77(1):53–7.PubMedCrossRefGoogle Scholar
  91. 89.
    Goldstein AT, Marinoff ST, Haefner HK. Vulvodynia treatment strategies. Clin Obstet Gynecol. 2005;48:769–85.PubMedCrossRefGoogle Scholar
  92. 90.
    Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102(1):84–7.PubMedCrossRefGoogle Scholar
  93. 91.
    Danielsson I, Torstensson T, Brodda-Jansen G, Bohm-Starke N. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand. 2006;85:1360–7.PubMedCrossRefGoogle Scholar
  94. 92.
    Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol. 2008;112:579–85.PubMedCrossRefGoogle Scholar
  95. 93.
    Nyirjesy P, Lev-Sagie A, Mathew L, Culhane JF. Topical amitriptyline-baclofen cream for the treatment of provoked vestibulodynia. J Low Genit Tract Dis. 2009;13:230–6.CrossRefGoogle Scholar
  96. 94.
    Murina F, Radici G, Bianco V. Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative. MedGenMed. 2004;6:48–56.PubMedGoogle Scholar
  97. 95.
    Updike GM, Wiesenfeld HC. Insight into treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol. 2005;193:1404–9.PubMedCrossRefGoogle Scholar
  98. 96.
    Brown CS, Wan J, Bachmann G, Rosen R. Self-management, amitriptyline, and amitriptyline plus triamcinolone in the management of vulvodynia. J Womens Health (Larchmt). 2009;18:163–9.CrossRefGoogle Scholar
  99. 97.
    Nyirjesy P, Sbel J, Witz MV, Small MJ, Gelone SP. Cromolyn cream, for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect. 2001;77:53–77.PubMedCrossRefGoogle Scholar
  100. 98.
    Hi G, Rodke G, Swenlonis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic feedback of pelvic floor musculature. J Reprod Med. 1996;40:283–90.Google Scholar
  101. 99.
    Bergeron S, Binik YM, Klalifé S, Pagidas K, Glazer HI, Meana M, Amsel R. A randomized comparison of group cognitive behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91:297–306.PubMedCrossRefGoogle Scholar
  102. 100.
    McKay E, Kaufman RH, Doctor U, Berkova Z, Glazer H, Redko V. Treating vulvar vestibulitis with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 2001;46:337–42.PubMedGoogle Scholar
  103. 101.
    Bergeron S, Klalifé S, Glazer HI, Meana M, Binik Y. Surgical and behavioral treatments for vestibulodynia: two-and-one-half-year follow-up and predictors of outcome. Obstet Gynecol. 2008;111:159–66.PubMedCrossRefGoogle Scholar
  104. 102.
    Reed BD, Haefner HK, Edwrads L. A survey on diagnosis and treatment of vulvodynia researchers and members of the International Society for the Study of Vulvar Disease. J Reprod Med. 2008;53:921–9.PubMedGoogle Scholar
  105. 103.
    Hartmann D, Starauhal MJ, Nelson CA. Treatment of women in the United States with localized, provoked vestibulodynia practice survey of women’s health physical therapists. J Reprod Med. 2007;52:48–52.PubMedGoogle Scholar
  106. 104.
    Backman H, Widenbrant M, Bohm-Starke N, Dahlof LG. Combined physical and psychosexual therapy for provoked vestibulodynia- an evaluation of a multidisciplinary treatment model. J Sex Res. 2008;45:378–85.PubMedCrossRefGoogle Scholar
  107. 105.
    Goldfinger C, Pukall CF, Gentilcore-Saulnier E, McLean L, Chamberlain S. A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med. 2009;6:1955–68.PubMedCrossRefGoogle Scholar
  108. 106.
    Forth HL, Cramp MC, Dreschsler WI. Does physiotherapy treatment improve the self-reported pain levels and quality of life of women with vulvodynia? A pilot study. J Obstet Gynaecol. 2009;29:423–9.PubMedCrossRefGoogle Scholar
  109. 107.
    Hartmann EH, Nelson C. The perceived effectiveness of physical therapy treatment on women complaining of chronic vulvar pain and diagnosed with either vulvar vestibulitis syndrome or dysesthetic vulvodynia. J Sect Womens Health. 2001;25:13–8.Google Scholar
  110. 108.
    Reed BD, Caron AM, Gorenflo DW, Haefner HK. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis. 2006;10:245–51.PubMedCrossRefGoogle Scholar
  111. 109.
    Munday PE. Response to treatment in dysaesthetic vulvodynia. J Obstet Gynaecol. 2001;6:610–13.CrossRefGoogle Scholar
  112. 110.
    Reed BD, Caron AM, Gorenflo DW, et al. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis. 2006;10:245–51.PubMedCrossRefGoogle Scholar
  113. 111.
    McKay M. Dysesthetic (“essential”) vulvodynia: treatment with amitriptyline. J Reprod Med. 1993;38:9–13.PubMedGoogle Scholar
  114. 112.
    Harris G, Horowitz B, Borigida A. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked. J Reprod Med. 2007;52:103–6.PubMedGoogle Scholar
  115. 113.
    Ben-Davod B, Friedman M. Gabapentin therapy for vulvodynia. Anesth Anal. 1999;89:1459–60.Google Scholar
  116. 114.
    Meltzer-Brody SE, Zolnoun D, Steege JF, Rinaldi KL, Leserman J. Open-label trial of lamotrigine focusing on efficacy in vulvodynia. J Reprod Med. 2009;54:171–8.PubMedGoogle Scholar
  117. 115.
    Jerome L. Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. Pain Res Manag. 2007;12:212–14.PubMedGoogle Scholar
  118. 116.
    Tinetti ME. Preventing falls in elderly persons. N Engl J Med. 2003;348:42–9.PubMedCrossRefGoogle Scholar
  119. 117.
    Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo-controlled, double blinded study. J Sex Med. 2009;6:2523–37.PubMedCrossRefGoogle Scholar
  120. 118.
    American Society Anesthesiologists Task Force. Practice guidelines for chronic pain management. Anesthesiology. 2010;112:8120–33.Google Scholar
  121. 119.
    Segal D, Tifheret H, Lazar S. Submucous infiltration of betamethasone and lidocaine in the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol. 2003;26(107):105–6.CrossRefGoogle Scholar
  122. 120.
    Murina F, Tassan P, Roberti P, Bianco V. Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine: an alternative approach. J Reprod Med. 2001;46:713–16.PubMedGoogle Scholar
  123. 121.
    Dede M, Yenen MC, Yilmaz A, Baser I. Successful treatment of persistent vulvodynia with submucous infiltration of betamethasone and lidocaine. Eur J Obstet Gynecol Reprod Biol. 2006;124:258–9.PubMedCrossRefGoogle Scholar
  124. 122.
    Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res. 2007;19:84–7.PubMedCrossRefGoogle Scholar
  125. 123.
    Gunter J, Brewer A, Tawfik O. Botulinum toxin A for vulvodynia: a case report. J Pain. 2004;5:238–40.PubMedCrossRefGoogle Scholar
  126. 124.
    Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. A deficiency in interferon-alpha production in women with vulvar vestibulitis. Am J Obstet Gynecol. 2002;186:361–4.PubMedCrossRefGoogle Scholar
  127. 125.
    Kent HL, Wisniewski PM. Interferon for vulvar vestibulitis. J Reprod Med. 1990;35:1138–40.PubMedGoogle Scholar
  128. 126.
    Marinoff SC, Turner ML, Hirsch RP, Richard G. Intralesional alpha interferon. Cost-effective therapy for vulvar vestibulitis syndrome. J Reprod Med. 1993;38:19–24.PubMedGoogle Scholar
  129. 127.
    Calvillo O, Skaribas IM, Rockett C. Computed tomography-guided pudendal nerve block. A new diagnostic approach to long-term anoperineal pain: a report of two cases. Reg Anesth Pain Med. 2000;25:420–3.PubMedGoogle Scholar
  130. 128.
    Stav K, Dwyer PL, Roberts F, Roberts L. Pudendal neuralgia: fact or fiction? Obstet Gynecol Surv. 2009;64:190–9.PubMedCrossRefGoogle Scholar
  131. 129.
    Toshniwal GR, Dureja GP, Prashanth SM. Transsacrococcygeal approach to ganglion impar block for management of chronic perineal pain: a prospective observational study. Pain Physician. 2007;10:661–6.PubMedGoogle Scholar
  132. 130.
    Goldstein AT, Klingman D, Christopher K, Johnson C, Marinoff SC. Surgical treatment of vulvar vestibulitis syndrome: outcome assessment derived from a postoperative questionnaire. J Sex Med. 2006;3:923–31.PubMedCrossRefGoogle Scholar
  133. 131.
    Eva LJ, Narain S, Orakwue CO, Luesley DM. Is modified vestibulectomy for localized provoked vulvodynia and effective long-term treatment? A follow-up study. J Reprod Med. 2008;53:435–40.PubMedGoogle Scholar
  134. 132.
    Bohm-Starke N, Rylander EJ. Surgery for localized, provoked vestibulodynia: a long-term follow-up study. J Reprod Med. 2008;53(2):83–9.PubMedGoogle Scholar
  135. 133.
    Trutnovsky G, Law C, Simpson JM, Mindel A. Use of complementary therapies in a sexual health clinic setting. Int J STD AIDS. 2001;12:307–9.PubMedCrossRefGoogle Scholar
  136. 134.
    Curran S, Brotto LA, Fisher H, Knudson G, Cohen T. The ACIV study: acupuncture treatment in provoked vestibulodynia. J Sex Med. 2010;7:981–95.PubMedCrossRefGoogle Scholar
  137. 135.
    Powell J, Wojnarowska F. Acupuncture for vulvodynia. J R Soc Med. 1999;92:579–81.PubMedGoogle Scholar
  138. 136.
    Brotto LA, Sadownik L, Thompson S. Impact of educational seminars on women with vestibulodynia. J Obstet Gynaecol Can. 2010;32:132–8.PubMedGoogle Scholar
  139. 137.
    Jensen JT, Wilder K, Car K, et al. Quality of life and sexual function after evaluation and treatment at a referral center for vulvovaginal disorders. Am J Obstet Gynecol. 2003;188:1629–37.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Jennifer Gunter
    • 1
  1. 1.Kaiser Permanente, Center for Pelvic PainSan FranciscoUSA

Personalised recommendations